💊Exclusive Patent License for CNS Therapeutics by NIH
The National Institute of Neurological Disorders and Stroke and the National Center for Advancing Translational Sciences, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this Notice to Psycala Bio, Inc. (Psycala), incorporated in Delaware.
Learn More🧬Exclusive Patent License Opportunity for Biomedical Innovations
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Cambridge Enterprise Limited, University of Cambridge, located in Cambridge, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
Learn More🚀NASA Notice
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More🚀NASA's Intent to Grant Exclusive Patent Licenses Overview
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More📡Notice of Intent to Grant Patent License to Dayton Photonics Systems
The Department of the Army hereby gives notice of its intent to grant to Dayton Photonics Systems LLC, a company having its principal place of business at 1800 E Whipp Road, Dayton, Ohio 45440, an exclusive license.
Learn More